About Intellectual Property IP Training Respect for IP IP Outreach IP for… IP and... IP in... Patent & Technology Information Trademark Information Industrial Design Information Geographical Indication Information Plant Variety Information (UPOV) IP Laws, Treaties & Judgements IP Resources IP Reports Patent Protection Trademark Protection Industrial Design Protection Geographical Indication Protection Plant Variety Protection (UPOV) IP Dispute Resolution IP Office Business Solutions Paying for IP Services Negotiation & Decision-Making Development Cooperation Innovation Support Public-Private Partnerships AI Tools & Services The Organization Working with WIPO Accountability Patents Trademarks Industrial Designs Geographical Indications Copyright Trade Secrets WIPO Academy Workshops & Seminars IP Enforcement WIPO ALERT Raising Awareness World IP Day WIPO Magazine Case Studies & Success Stories IP News WIPO Awards Business Universities Indigenous Peoples Judiciaries Genetic Resources, Traditional Knowledge and Traditional Cultural Expressions Economics Gender Equality Global Health Climate Change Competition Policy Sustainable Development Goals Frontier Technologies Mobile Applications Sports Tourism PATENTSCOPE Patent Analytics International Patent Classification ARDI – Research for Innovation ASPI – Specialized Patent Information Global Brand Database Madrid Monitor Article 6ter Express Database Nice Classification Vienna Classification Global Design Database International Designs Bulletin Hague Express Database Locarno Classification Lisbon Express Database Global Brand Database for GIs PLUTO Plant Variety Database GENIE Database WIPO-Administered Treaties WIPO Lex - IP Laws, Treaties & Judgments WIPO Standards IP Statistics WIPO Pearl (Terminology) WIPO Publications Country IP Profiles WIPO Knowledge Center WIPO Technology Trends Global Innovation Index World Intellectual Property Report PCT – The International Patent System ePCT Budapest – The International Microorganism Deposit System Madrid – The International Trademark System eMadrid Article 6ter (armorial bearings, flags, state emblems) Hague – The International Design System eHague Lisbon – The International System of Appellations of Origin and Geographical Indications eLisbon UPOV PRISMA UPOV e-PVP Administration UPOV e-PVP DUS Exchange Mediation Arbitration Expert Determination Domain Name Disputes Centralized Access to Search and Examination (CASE) Digital Access Service (DAS) WIPO Pay Current Account at WIPO WIPO Assemblies Standing Committees Calendar of Meetings WIPO Webcast WIPO Official Documents Development Agenda Technical Assistance IP Training Institutions COVID-19 Support National IP Strategies Policy & Legislative Advice Cooperation Hub Technology and Innovation Support Centers (TISC) Technology Transfer Inventor Assistance Program WIPO GREEN WIPO's Pat-INFORMED Accessible Books Consortium WIPO for Creators WIPO Translate Speech-to-Text Classification Assistant Member States Observers Director General Activities by Unit External Offices Job Vacancies Procurement Results & Budget Financial Reporting Oversight
Arabic English Spanish French Russian Chinese
Laws Treaties Judgments Browse By Jurisdiction

Papua New Guinea

PG032

Back

Drugs Regulations 1958

Drugs Regulation 1958

Unvalidated References: Drugs Act 1952

This reprint of this Statutory Instrument incorporates all amendments, if any, made before 25 November 2006 and in force at 1 July 2001.

......... Legislative Counsel Dated 25 November 2006

INDEPENDENT STATE OF PAPUA NEW GUINEA.

Chapter 229.

Drugs Regulation 1958

ARRANGEMENT OF SECTIONS.

1. Interpretation.

2. Editions in force.

3. Standards of drugs, etc.

Drugs Regulation 1958

MADE under the Drugs Act 1952 .

Dated 200 .

1. INTERPRETATION.

In this Regulation–

“the British Pharmacopoeia” means the British Pharmacopoeia as published in the United Kingdom under the direction of the General Medical Council, in the edition for the time being in force, together with any Addendum to the British Pharmacopoeia so published; “the Codex” means the British Pharmaceutical Codex published in the United Kingdom by direction of the Council of the Pharmaceutical Society of Great Britain, in the edition for the time being in force, together with any Supplement to the British Pharmaceutical Codex so published; “the Formulary” means the Australian Pharmaceutical Formulary (A.P.F.) published in Australia by the Pharmaceutical Association of Australia, in the edition for the time being in force.

2. EDITIONS IN FORCE.

The Departmental Head may, by notice in the National Gazette, declare which edition of the British Pharmacopoeia, the Codex or the Formulary, and which Addendum to the British Pharmacopoeia or Supplement to the British Pharmaceutical Codex, is for the time being in force for the purposes of the Act and this Regulation.

3. STANDARDS OF DRUGS, ETC.

For the purposes of the Act–

(a) the standards for the composition of drugs, disinfectants and preservatives; and (b) the amount of dilution (if any) to be allowed in the sale by retail of drugs, disinfectants and preservatives; and (c) the standards of the amount of deterioration or natural poverty (if any) in a drug to be permitted without prosecution under the Act,

are as laid down–

(d) in the British Pharmacopoeia; or (e) if there be no such matter laid down in the British Pharmacopoeia in the particular case–in the Codex; or (f) if there be no such matter laid down in the British Pharmacopoeia or the Codex in the particular case–in the Formulary.

Office of Legislative Counsel, PNG